Kirkland Signature Smoked Salmon products recalled in October 2024 are now considered to be a Class 1 recall, the FDA’s most ...

Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

Brooke Rollins likely has the support to secure Senate confirmation, though members from both political parties raised ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 7 includes Village Super Market, MARA Holdings, ...